# Magellan Bioscience Group Inc — Form D

Magellan Bioscience Group Inc of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-17. The offering totals $100K, of which $25K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2012-09-17
- Form: D
- Accession: 0001558050-12-000001
- Industry: Biotechnology
- Exemptions: 05, 06
- Total offering: $100K
- Amount sold: $25K
- Remaining: $75K
- Minimum investment: $1K
- Investors: 2
- Security types: equity
- Revenue range: $1 - $1,000,000

## Issuer

- Name: Magellan Bioscience Group Inc
- CIK: 0001558050
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 4519 GEORGE ROAD, SUITE 120, TAMPA, FL, 33634
- Phone: 813-884-3131

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| James Carr Gamble III | Director | New York, NY |
| Christopher Carr Mallavarapu | Director | Lafayette, LA |
| John Michael Cronan | Executive Officer | Tampa, FL |

## More

- [CIK 1558050 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1558050&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001558050-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.